APA (7th ed.) Citation

Utay, N., Gottwald, M., Chang, W., Willett, M., & Lefebvre, E. (2015). P0146: Oral, once-daily, cenicriviroc leads to rapid and potent CCR2 and CCR5 blockade in subjects with advanced liver disease, similar to effects seen in healthy volunteers and HIV-1 infected subjects. Journal of Hepatology, 62, S356. https://doi.org/10.1016/S0168-8278(15)30366-4

Chicago Style (17th ed.) Citation

Utay, N.S, M. Gottwald, W. Chang, M.S Willett, and E. Lefebvre. "P0146: Oral, Once-daily, Cenicriviroc Leads to Rapid and Potent CCR2 and CCR5 Blockade in Subjects with Advanced Liver Disease, Similar to Effects Seen in Healthy Volunteers and HIV-1 Infected Subjects." Journal of Hepatology 62 (2015): S356. https://doi.org/10.1016/S0168-8278(15)30366-4.

MLA (9th ed.) Citation

Utay, N.S, et al. "P0146: Oral, Once-daily, Cenicriviroc Leads to Rapid and Potent CCR2 and CCR5 Blockade in Subjects with Advanced Liver Disease, Similar to Effects Seen in Healthy Volunteers and HIV-1 Infected Subjects." Journal of Hepatology, vol. 62, 2015, p. S356, https://doi.org/10.1016/S0168-8278(15)30366-4.